Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

2.
4.
6.

Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.

Bahr GM, Darcissac EC, Castéran N, Amiel C, Cocude C, Truong MJ, Dewulf J, Capron A, Mouton Y.

J Virol. 2001 Aug;75(15):6941-52.

7.
8.
9.

Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells.

Truong MJ, Darcissac EC, Hermann E, Dewulf J, Capron A, Bahr GM.

J Virol. 1999 Aug;73(8):7008-13.

10.

Selective potentiation of cytokine expression in human whole blood by murabutide, a muramyl dipeptide analogue.

Darcissac EC, Bahr GM, Pouillart PR, Riveau GJ, Parant MA.

Cytokine. 1996 Aug;8(8):658-66.

PMID:
8894442
11.

Selective induction of CD11a,b,c/CD18 and CD54 expression at the cell surface of human leukocytes by muramyl peptides.

Darcissac EC, Bahr GM, Parant MA, Chedid LA, Riveau GJ.

Cell Immunol. 1996 May 1;169(2):294-301.

PMID:
8620558
12.

Modulation of expression of class II MHC and CD40 molecules in murine B cells by various muramyl dipeptides.

Cohen LY, Bahr GM, Darcissac EC, Parant MA.

Cell Immunol. 1996 Apr 10;169(1):75-84.

PMID:
8612298

Supplemental Content

Loading ...
Support Center